APA (7th ed.) Citation

A, G., JE, S., G, L., G, C., L, N., JS, H., . . . S, V. (2022). Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation. Clinical transplantation, 36(5), e14616. https://doi.org/10.1111/ctr.14616

Chicago Style (17th ed.) Citation

A, Galeone, et al. "Suppression of Tumorigenicity-2 (ST2) Is a Promising Biomarker in Heart Transplantation." Clinical Transplantation 36, no. 5 (2022): e14616. https://doi.org/10.1111/ctr.14616.

MLA (9th ed.) Citation

A, Galeone, et al. "Suppression of Tumorigenicity-2 (ST2) Is a Promising Biomarker in Heart Transplantation." Clinical Transplantation, vol. 36, no. 5, 2022, p. e14616, https://doi.org/10.1111/ctr.14616.